Product Information
CL-82198 is a potent inhibitor of Toll-like receptor 4 (TLR4) and has been shown to inhibit the growth of cancer cells. It induces the expression of genes that are up-regulated in both bowel disease and cancer tissues, such as collagen, protease activity, and epidermal growth factor. CL-82198 also inhibits the production of inflammatory cytokines such as IL-1β, IL-6, and TNFα. CL-82198 is currently being studied for its potential use in the treatment of diabetic neuropathy and inflammatory bowel disease.
Chemical properties
Technical inquiry about: 3D-HMA00271 CL-82198
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
